Gilead Sciences (United States)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
59%
Total
Publications
5K
Total Open
Publications
3K
Total
Citations
234K
Open Access
Percentage
59%
Total
Publications
5K
Total Open
Publications
3K
Total
Citations
234K
Breakdown
Publisher Open
23%
Both
25%
Other Platform Open
11%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
694
Hybrid 30%
726
No Guarantees 41%
1K
Other Platform Open
Domain 88%
1.6K
Institution 23%
419
Other Internet 9%
173
Public 7%
135
Preprint 5%
93
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.6K |
Europe PMC | Domain | 917 |
Semantic Scholar | Public | 111 |
DOI | Other Internet | 83 |
California Digital Library - eScholarship | Other Internet | 58 |
University of California - eScholarship University of California | Institution | 51 |
University College London - UCL Discovery | Institution | 50 |
bioRxiv | Preprint | 48 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 46 |
Figshare | Public | 30 |